The second symptom is cataplexy that means a sudden loss of muscle tone, that happens quickly and also there isn’t any approach these approaches can be estimated. Various other several signals include hallucinations or the state in between alert as well as slumber, which are being experienced as a film that’s running by way of the head In addition an individual that suffers from this illness from time to time experience sleep paralysis that on occasions can continue up to a few minutes.

The most common side effects in case of an overdose – substantial bloodstream pressure, chest discomfort, sleep loss, anxiety, a few people could really feel baffled. There are also some other side effects which are not stated here, so you will will need to communicate to a doctor along with obtain a full record from him.

People that due to the nature of the jobs have to do extended hours, just like van drivers that need to invest lengthy hours in the driver’s seat, as well as therefore normally feel affected by drowsiness.

The dilemma is the fact that for operators remaining alert is crucial as experiencing drained could steer into an elevated variety of crashes. Provigil (modalert) medicine a well-known stimulant is assisting to remain alert instead of to fall asleep driving.

• Cataplexy ( loss of muscle tone that happens suddenly)
• Hallucinations
• The second one is sleep paralysis
• The most common one – excessive sleepiness

The reason that causes Narcolepsy is still unknown. This disorder can happen at any time, and all age groups can be affected, however more often it starts between 1o to 25 years, however some people develop these symptoms after 35 years.

It is thought that because it’s reducing the symptoms of depression people tend to eat less and as a result lose weight, however this effect needs to be studies further, so it is not currently prescribed for weight loss.

Provigil is a category C medication, which tell us that there has been no study performed on humans to establish whether it passes through the breast milk. However, because mosy other mdicines do so, it is a fair assumption that Provigil does exactly the same thing.

Provigil has to be used with a caution, as it has got a few side effects.

It also can happen in patients with dementia. Depression is very often mistaken for apathy.

One of the medicines which is prescribed to these patients is Provigil. One of the reasons for that is that Provigil is very well tolerated when is taken with other medicines. This is a very important thing for aged patients, as they usually take lots of medications.

Potentially it can also be used to treat people who did not respond well to the treatment by antidepressants.

It has been proven, that split doses were much more effecient than once a day dose ( 200 mg of Provigil), and it was better performing in sustaining wakefulness in the evening.

Both these regimes are very well tolerated. Therefore please consult your doctor to decide which regime is better and more suitable for your needs

Hundreds of cocaine users are testing whether that legal pill, called Provigil, could help them kick the addiction, and there’s early evidence that it may.

In addition to blunting cocaine’s notorious cravings, Provigil might also counter the damage that cocaine wreaks on users’ brain circuits — damage that, in turn, fuels the cycle of addiction.

The prospect of that double-whammy has the National Institutes of Health spending $10.8 million researching Provigil as a potential cocaine treatment.

Results from the first of three key clinical trials could arrive by year’s end.

Scientists are cautious.

In a hunt spanning two decades, no one has found a medication to help treat cocaine addiction, and there’s no guarantee that Provigil will pan out.

But for Dr. Nora Volkow, director of the NIH’s National Institute on Drug Abuse, the narcolepsy medicine tops the list of promising potential therapies.

It may help restore proper function of a crucial brain chemical, dopamine, that addiction hijacks.

And in describing why he’s hopeful, one leading researcher recounts the man who accused his drug dealer of selling bad coke before realizing Provigil had kept him from getting high — and several other Provigil testers who told of flushing cocaine down the toilet.

”I’ve been treating cocaine-addicted patients for something like 25 years, more, and I’ve never heard of anybody throwing away cocaine,” said Dr. Charles Dackis, of the University of Pennsylvania.

He led a pilot study that suggested Provigil more than doubled cocaine addicts’ chances of going cocaine-free for a period of at least three weeks.

That study enrolled just 62 people, but the results were significant enough for the NIH to fund new research — at Pennsylvania, the University of Texas in Houston, Boston University and other sites — enrolling about 650 cocaine users to see if Provigil really does work.

The main side effect so far: insomnia, not surprising as Provigil is sold today to help narcolepsy patients fend off that neurological disease’s sudden sleep attacks.

Addiction specialists gave it a look because even though Provigil isn’t a classic stimulant, it triggered something in the brain to also improve patients’ mood, energy levels and ability to concentrate — effects that might counter cocaine withdrawal. Then came the surprises:

Cocaine intensely stimulates the brain’s pleasure centers, producing not just a ”buzz” or a ”rush,” but outright euphoria. In a small safety study to ensure that Provigil didn’t make cocaine worse, some users found the pill blocked that high.

Provigil seems to increase activity in the prefrontal cortex, the brain’s decision-making command center and the spot that allows reasoning to override impulse or emotion. Cocaine reduces activity in that key brain region, making it even harder for would-be quitters to ignore cravings.

Provigil also increases the ability to think strategically, a means of weighing variables and risks to make decisions, says Frank Vocci, NIDA’s pharmacotherapy chief.

Cocaine is highly addictive: About 16 percent of people who try it become hooked.

In the latest data, from 2003, the government estimated that more than 1.5 million Americans were dependent on or abusing cocaine, and more reported recently experimenting with it.

Cerebral palsy continues to be a difficult condition to treat.3-5 Many patients with cerebral palsy have easily identified structural abnormalities of the brain, and current treatments are limited and almost never curative.  Available standard treatments for cerebral palsy include oral muscle relaxants, botulinum toxin injections, baclofen pump, dorsal rhizotomy, and orthopedic procedures. Tizanidine, an oral muscle relaxant, has several bothersome side effects, such as drowsiness, dry mouth, and increased liver enzymes.

Dantrolene’s side effects include sedation, malaise, and weakness. Benzodiazepines can cause drowsiness, fatigue, muscle weakness, and drooling.  Baclofen causes sedation, dizziness, weakness, and seizures.  Botulinum toxin injections are associated with general anesthesia risks, the pain of the procedure, the risk of development of antibodies, and the potential for overdosage, resulting in muscle weakness.14-16 The baclofen pump is associated with the risks of surgery and anesthesia, infections, pump malfunction, medication withdrawal, and possible seizures. Bleeding, spinal cord damage, infection, and procedure failure are concerns with posterior rhizotomy. Orthopedic procedures are associated with anesthesia and surgical risks.

Provigil offers a potential new approach in the treatment of cerebral palsy. Provigil is the only published treatment for cerebral palsy with a proposed central nervous system mechanism of action to improve motor performance. The current standard treatment options for cerebral palsy have also given poor results. A recent review of oral medications for spasticity noted poorly documented benefits.  Provigil has fewer bothersome side effects than the other available oral treatments. With side effects, such as sedation and muscle hypotonia, there are major drawbacks in the use of oral muscle relaxants for spasticity.

In the current study, children with spastic diplegia secondary to prematurity noted marked improvement in hypertonia in the lower extremities, resulting in better gait. Although not previously mentioned in this study, patients with spastic hemiplegia also noted gait and hand function improvements. All patients with spastic hemiplegia were ambulatory during this study. Patients with spastic quadriplegia showed improvements in tone and comfort level. All patients with spastic quadriplegia were nonambulatory during this study. Thus, each group saw improvements with Provigil treatment during the study; however, only the children treated with Provigil for spastic diplegia were noted to become ambulatory.

Provigil appears to be well tolerated at the modest doses (3 mg/kg) used in this group of patients. Some of our families and patients prefer to substitute Provigil for one of their previous treatments, such as baclofen or botulinum toxin. The current study reinforces the previous Provigil study results and shows that Provigil treatment can be associated with functional improvements, such as ambulation, in at least some cerebral palsy patients. According to one patient’s mother, the mother’s hope that her daughter will walk someday has not only been restored but also achieved (case 2).

Pain is processed in the nuclei ventralis posterolateralis, which is adjacent to the ventrolateral nucleus of the thalamus. The ventrolateral nucleus, a site of action for Provigil, receives input from the ventralis posterolateralis. Provigil has been shown to affect somatosensory input processing in the human brain stem.  Provigil interferes with the processing of somatosensory ascending inputs and therefore can reduce the perception of pain.  When fatigued, patients with cerebral palsy suffer motor performance deterioration, increased spasticity, and decreased motor endurance. This might explain why some patients with cerebral palsy appear to be both less spastic and in less pain while on Provigil.

This study was a retrospective review and therefore has limitations. The patients studied did not have a uniform prospective evaluation. Major changes in functioning and physical examination were seen, but subtle changes or minor improvements could have been missed, certainly underestimating the benefit to Provigil treatment. Provigil was stopped at any time for any parental concern; a quick to discontinue approach was used. This probably overstates the side-effect rate to Provigil.

A case-control review of this study is, however, possible.  Comparing all patients on Provigil treatment with all patients not on Provigil treatment does not control for the degree of disability. Since there are more nonambulatory patients in the non-Provigil-treated group, this comparison cannot be made. Likewise, those subgroups consisting of patients with assisted gait, who are nonambulatory, and who are walking in water are too small to be statistically analyzed. However, those patients with previous ambulation are, in general, matched for age and degree of disability and are representative of a large subgroup of people with cerebral palsy. The focus of the current study was gait improvement, which was noted in the previous ambulation subgroup. Using this subgroup of patients, 27 Provigil-treated patients were noted with gait improvement and 10 Provigil-treated patients were not noted with gait improvement. Three non-Provigil-treated patients were noted with gait improvement and 17 non-Provigil-treated patients were not noted with gait improvement. The calculated odds ratio of this patient distribution is 15.3, with a 95% confidence interval of 3.677 to 63.667.  The calculated P value is less than .0001. This is a highly statistically significant result favoring a therapeutic response to Provigil.

Because of diverse etiologies and unique individual patient profiles, cerebral palsy will remain a complex treatment area. The Provigil-treated patients in this study with spastic diplegia are walking better. This effect is unlikely to be a placebo response because it is contrary to the chronic natural history of cerebral palsy. The other Provigil-treated patients in this review also showed improvements in tone and mobility and reduced pain. The non-Provigil-treated group did not display such prominent gains in gait or mobility. The differences in treatment results remain striking. For cerebral palsy, a condition that is chronic and incurable, a new treatment, which reduces tone and has a benign side-effect profile compared with the other available treatments, appears to be available in the central nervous system stimulant Provigil.

The study was performed at Texas Tech University Health Sciences Center. This study was presented at the 34th Annual Meeting of the Child Neurology Society, Los Angeles, CA, September 28-October 1, 2005.